September 2020: Origin Merchant Partner Advises LifeSpeak on its $42 million Equity Investment

September 2020: Origin Merchant Partner Advises LifeSpeak on its $42 million Equity Investment

By Tracey Lamping's

All Transactions, Financings & Capital Raisings

September 16, 2020

Origin Merchant Partners is pleased to announce that LifeSpeak Inc. (“Lifespeak”) has raised $42 million in an equity investment from a syndicate including Round13 Growth Fund, Roynat Capital, and Kensington Capital Partners. Origin Merchant Partners was the exclusive financial advisor to LifeSpeak with respect to this transaction.

LifeSpeak is a leading digital mental health and wellness education platform, providing employees, health plan members and their families with remote access to leading experts in mental health, physical wellness, financial health, family relationships and professional skills development, through a proprietary collection of content and tools. A North American leader in well-tech, LifeSpeak has a well-established 16 year track record of effectiveness, engagement and client retention.

Round13 Growth Fund (“Round13”) invests in Canadian based growth opportunities including those in technology and healthcare, as well as more traditional industries where there is an opportunity for technology enablement. Round13 helps to bridge the late-stage growth funding gap in Canada between traditional venture capital and public market investors.

Roynat Inc.(“Roynat”) is a wholly owned subsidiary of Scotiabank, one of North America’s premier financial institutions and Canada’s international bank. Roynat provides alternative financing solutions to Canadian mid-market businesses.

Kensington Capital Partners (“Kensington”) is a leading Canadian alternative investment firm with $ 1.5 billion in assets under management. Kensington’s portfolio of innovative investments includes diversified funds focused on private equity, venture capital, infrastructure assets and hedge funds.

Origin Senior Leads: Mario Di Pietro, Cathy Steiner, Christopher Solda